Growth Metrics

Phibro Animal Health (PAHC) Raw Materials (2016 - 2025)

Phibro Animal Health has reported Raw Materials over the past 13 years, most recently at $178.5 million for Q4 2025.

  • Quarterly results put Raw Materials at $178.5 million for Q4 2025, up 22.34% from a year ago — trailing twelve months through Dec 2025 was $178.5 million (up 22.34% YoY), and the annual figure for FY2025 was $162.6 million, up 123.39%.
  • Raw Materials for Q4 2025 was $178.5 million at Phibro Animal Health, up from $166.4 million in the prior quarter.
  • Over the last five years, Raw Materials for PAHC hit a ceiling of $178.5 million in Q4 2025 and a floor of $59.8 million in Q2 2021.
  • Median Raw Materials over the past 5 years was $84.8 million (2022), compared with a mean of $99.5 million.
  • Biggest five-year swings in Raw Materials: decreased 20.21% in 2023 and later soared 123.39% in 2025.
  • Phibro Animal Health's Raw Materials stood at $71.3 million in 2021, then skyrocketed by 35.44% to $96.6 million in 2022, then dropped by 20.21% to $77.0 million in 2023, then soared by 89.35% to $145.9 million in 2024, then grew by 22.34% to $178.5 million in 2025.
  • The last three reported values for Raw Materials were $178.5 million (Q4 2025), $166.4 million (Q3 2025), and $162.6 million (Q2 2025) per Business Quant data.